Cardiovascular Stock Price, News & Analysis
Company Description
Cardiovascular (NASDAQ: CSII) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $844.0M.
CSII stock has gained 0.1% over the past year.
This page provides a comprehensive overview of CSII stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cardiovascular (CSII) stock. Over the past 12 months, the stock has gained 0.1%. At a market capitalization of $844.0M, CSII is classified as a small-cap stock with approximately 42.2M shares outstanding.
Latest News
Cardiovascular has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include clinical trial, earnings, conferences, fda approval. View all CSII news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CSII Company Profile & Sector Positioning
Cardiovascular (CSII) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing CSII often look at related companies in the same sector, including Tandem Diabetes (TNDM), Axogen Inc (AXGN), Inmode Ltd. (INMD), Intersect Ent (XENT), and Iradimed Corp (IRMD). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CSII's relative position within its industry.